ARCH Venture Fund XIII, L.P. - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: LYEL on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Fund XIII, L.P. since 11/22/2024

Holdings reported by ARCH Venture Fund XIII, L.P. for Lyell Immunopharma, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	938K	$375K	$0.40	Jul 25, 2025	By: ARCH Venture Fund XIII, L.P.

There are no transactions reported by ARCH Venture Fund XIII, L.P. for Lyell Immunopharma, Inc.